Lantern Pharma (LTRN) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChartTranscripts

Lantern Pharma Revenue Highlights


00

Lantern Pharma Revenue by Period


Lantern Pharma Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

Lantern Pharma generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Lantern Pharma Revenue by Quarter

DateRevenueChange
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$261.05K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--

Lantern Pharma generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Lantern Pharma Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
IMNMImmunome$14.02M$2.36M
GBIOGeneration Bio$5.90M$4.06M
CUECue Biopharma$5.49M$1.72M
LYRALyra Therapeutics$1.56M$598.00K
TFFPTFF Pharmaceuticals$733.87K$650.22K
LTRNLantern Pharma--

LTRN Revenue FAQ


Lantern Pharma's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. LTRN's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

Lantern Pharma's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). LTRN's quarterly revenue for Q4 2023 was $261.05K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

Lantern Pharma's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.